Douglas  Corley  to  Genome-Wide Association Study
                            
                            
                                This is a "connection" page, showing publications  Douglas  Corley  has written about  Genome-Wide Association Study.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            1.220
         
        
        
     
 
    
        
        - 
            Constrained Score Statistics Identify Genetic Variants Interacting with Multiple Risk Factors in Barrett's Esophagus. Am J Hum Genet. 2016 08 04; 99(2):352-65.
            
            
                Score: 0.240
            
         
        
        - 
            Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis. Lancet Oncol. 2016 Oct; 17(10):1363-1373.
            
            
                Score: 0.120
            
         
        
        - 
            Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma. Carcinogenesis. 2014 Dec; 35(12):2740-7.
            
            
                Score: 0.106
            
         
        
        - 
            Unraveling the genetic landscape of susceptibility to multiple primary cancers. HGG Adv. 2025 Apr 10; 6(2):100413.
            
            
                Score: 0.054
            
         
        
        - 
            Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations. Nat Commun. 2023 10 02; 14(1):6147.
            
            
                Score: 0.049
            
         
        
        - 
            Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries. Nat Genet. 2023 01; 55(1):89-99.
            
            
                Score: 0.047
            
         
        
        - 
            Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma. Carcinogenesis. 2021 04 17; 42(3):369-377.
            
            
                Score: 0.042
            
         
        
        - 
            Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts. Nat Commun. 2021 02 12; 12(1):970.
            
            
                Score: 0.041
            
         
        
        - 
            Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterology. 2020 12; 159(6):2065-2076.e1.
            
            
                Score: 0.040
            
         
        
        - 
            Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts. Nat Commun. 2020 09 04; 11(1):4423.
            
            
                Score: 0.040
            
         
        
        - 
            Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk. Am J Hum Genet. 2020 09 03; 107(3):432-444.
            
            
                Score: 0.040
            
         
        
        - 
            Cumulative Burden of Colorectal Cancer-Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer. Gastroenterology. 2020 04; 158(5):1274-1286.e12.
            
            
                Score: 0.038
            
         
        
        - 
            Association Between Levels of Sex Hormones and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus. Clin Gastroenterol Hepatol. 2020 11; 18(12):2701-2709.e3.
            
            
                Score: 0.038
            
         
        
        - 
            Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants. Gastroenterology. 2018 04; 154(5):1273-1281.e3.
            
            
                Score: 0.033
            
         
        
        - 
            Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma. Gut. 2017 10; 66(10):1739-1747.
            
            
                Score: 0.030
            
         
        
        - 
            A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus. Cancer Epidemiol Biomarkers Prev. 2015 Nov; 24(11):1739-47.
            
            
                Score: 0.028
            
         
        
        - 
            Pleiotropic analysis of cancer risk loci on esophageal adenocarcinoma risk. Cancer Epidemiol Biomarkers Prev. 2015 Nov; 24(11):1801-3.
            
            
                Score: 0.028
            
         
        
        - 
            MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium. PLoS One. 2015; 10(6):e0128617.
            
            
                Score: 0.028
            
         
        
        - 
            Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort. PLoS Genet. 2015 Jan; 11(1):e1004930.
            
            
                Score: 0.027
            
         
        
        - 
            Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus. Gastroenterology. 2015 Feb; 148(2):367-78.
            
            
                Score: 0.027
            
         
        
        - 
            Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study. J Natl Cancer Inst. 2014 Nov; 106(11).
            
            
                Score: 0.026
            
         
        
        - 
            Most common 'sporadic' cancers have a significant germline genetic component. Hum Mol Genet. 2014 Nov 15; 23(22):6112-8.
            
            
                Score: 0.026
            
         
        
        - 
            Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux. J Natl Cancer Inst. 2013 Nov 20; 105(22):1711-8.
            
            
                Score: 0.025
            
         
        
        - 
            A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet. 2013 Dec; 45(12):1487-93.
            
            
                Score: 0.025
            
         
        
        - 
            Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet. 2012 Oct; 44(10):1131-6.
            
            
                Score: 0.023